Research Article

Potential Predictors of Poor Prognosis among Severe COVID-19 Patients: A Single-Center Study

Table 1

Patients’ demographics, clinical data, and laboratory data.

Medians (interquartile ranges)FrequenciesCutoff
N%

Age (years)M: 53 ± 15
F: 59 ± 20
All: 56 ± 17
20–5910666.3
≥605433.8

Sex
Female4025
Male12075

Diabetes
Yes5232.5
No10867.5

Renal failure
Yes53
No15597

Pulmonary disease
Yes7849
No8251

Heart disease
Yes4328
No10972

Ferritin1229 (770–1853)Male: 30–400 ug/L
Female: 15–150 ug/L
Normal64
Increased13996

D-dimer4 (2–12)All: 0–0.55 mg/L
Normal64
Increased13196

AST58 (29–99)All: 15–37 U/L
Normal5032
Increased10768

ALT42 (27–92)All: 14–36 U/L
Normal10366
Increased5234

ALP24 (20–30)All: 46–120 U/L
Decreased146100
Normal00

Total protein68 (63–71)All: 64–82 g/L
Decreased2226
Normal6274

Bilirubin total13 (8–22)All: 0–18.7 umol/L
Normal9775
Increased3225

Bilirubin nonconjugated6 (3–15)3.4–12 umol/L
Normal3830
Increased8970

Creatinine243 (114–508)Male: 62–115 umol/L
Female: 44–90 umol/L
Normal5638
Increased9362

BUN24 (9–39)All: 2.6–6.4 mmol/L
Normal4732
Increased10268

CRP8 (2–13)All: 0–6 mg/L
Normal5342
Increased7458

RBCs4 (3–5)Male: 4.5–5.5 10^12/L
Female: 3.8–4.8 10^12/L
Decreased9057
Normal6743

Hb97 (81–121)Male: 130–170 g/L
Female: 120–150 g/L
Decreased10365
Normal5535

Neutrophils89 (80–92)2–7 10^9/L
Normal4129
Increased10271

Eosinophils0 (0–2)0.1–0.8 10^9/L
Decreased8962
Normal5438

Basophils0 (0–0)0.02–0.1 10^9/L
Decreased10573
Increased3827

Monocytes4 (2–7)0.2–1 10^9/L
Decreased3524
Normal10876

Lymphocytes7 (4–13)1–4 10^9/L
Decreased11983
Normal2417

Discharge status
Cured6742
Died9358
Overall160100

N: number of patients; M: male; F: female; all: both male and female; SD: standard deviation; BUN: blood urea nitrogen; CRP: C-reactive protein; Hb: hemoglobin; AST: aspartate aminotransferase; ALT: alanine aminotransferase; ALP: alkaline phosphatase. †Mean ± SD.Cutoff for laboratory tests.